Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Mayo Clinic Laboratories, |
RCV001507814 | SCV001713613 | uncertain significance | not provided | 2020-03-30 | criteria provided, single submitter | clinical testing | |
Athena Diagnostics | RCV001507814 | SCV001880407 | uncertain significance | not provided | 2020-10-29 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV001785821 | SCV002027682 | uncertain significance | Charlevoix-Saguenay spastic ataxia | 2021-09-05 | criteria provided, single submitter | clinical testing | |
Genome Diagnostics Laboratory, |
RCV001847284 | SCV002104967 | uncertain significance | Hereditary spastic paraplegia | 2018-12-01 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001865926 | SCV002151774 | likely benign | Spastic paraplegia | 2023-11-21 | criteria provided, single submitter | clinical testing | |
Natera, |
RCV001785821 | SCV002086157 | uncertain significance | Charlevoix-Saguenay spastic ataxia | 2020-07-07 | no assertion criteria provided | clinical testing |